Regulatory support for innovative cancer therapies is improving approval timelines.Fast-track designations are accelerating drug commercialization.These supportive frameworks enhance industry growth prospects The Bladder Cancer Therapeutics and Diagnostics Market is projected to register a robust CAGR of 10.2% from 2025 to 2031, with market size expanding significantly from US$ XX million in...